감염증 감시 솔루션 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global infection surveillance solutions market size is expected to reach USD 2360.89 Million in 2034 from USD 755.29 Million in 2025, growing at a CAGR of 13.5% during 2026-2034.The infection surveillance solutions market is poised for significant growth, driven by the increasing need for effective infection control and prevention strategies in healthcare settings. As the global burden of healthcare-associated infections (HAIs) continues to rise, healthcare facilities are prioritizing the implementation of robust surveillance systems to monitor and manage infection outbreaks. These solutions enable healthcare providers to collect, analyze, and report data on infection rates, facilitating timely interventions and improving patient safety. Innovations in data analytics, artificial intelligence, and machine learning are enhancing the capabilities of infection surveillance systems, allowing for real-time monitoring and predictive analytics that can identify potential outbreaks before they escalate.

Moreover, the growing emphasis on regulatory compliance and quality improvement initiatives is influencing the infection surveillance solutions market. Healthcare organizations are increasingly required to adhere to stringent guidelines and reporting standards set by regulatory bodies, driving the demand for comprehensive surveillance solutions that ensure compliance. Additionally, the rise of value-based care models is prompting healthcare providers to focus on improving patient outcomes and reducing costs associated with infections, further fueling the adoption of infection surveillance technologies.

Furthermore, the COVID-19 pandemic has underscored the importance of infection surveillance in managing public health crises. The need for effective tracking and reporting of infectious diseases has led to increased investments in surveillance technologies, not only in hospitals but also in public health agencies. The integration of mobile health applications and telehealth platforms is also enhancing the accessibility and efficiency of infection surveillance solutions, enabling healthcare providers to monitor infections in real-time and respond swiftly to emerging threats. In summary, the infection surveillance solutions market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to improving patient safety and public health.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Products and Services

• Software
• Services

By Infection Type

• Surgical Site Infections
• Blood Stream Infections
• Urinary Tract Infections

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Becton, Dickinson and Company, Premier, Inc., Oracle Corporation, Wolters Kluwer N.V., Baxter International Inc., Clinisys Group, GOJO Industries, Inc., Merative, Inc., VigiLanz Corporation, RLDatix, Ecolab Inc., Harris Healthcare, PeraHealth, Inc., Medexter Healthcare GmbH, CenTrak, Inc., bioMerieux S.A., PointClickCare Technologies Inc., Vitalacy Inc., BioVigil Healthcare Systems, Vecna Technologies, Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY PRODUCTS AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products And Services
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY INFECTION TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Infection Type
• 5.2. Surgical Site Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood Stream Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urinary Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Products And Services
  • 7.2.2 By Infection Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Products And Services
  • 7.3.2 By Infection Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Products And Services
  • 7.4.2 By Infection Type
  • 7.4.3 By End User
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Products And Services
  • 7.5.2 By Infection Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Products And Services
  • 7.6.2 By Infection Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INFECTION SURVEILLANCE SOLUTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Becton, Dickinson And Company
  • 9.2.2 PremierInc
  • 9.2.3 Oracle Corporation
  • 9.2.4 Wolters Kluwer N.V
  • 9.2.5 Baxter International Inc
  • 9.2.6 Clinisys Group
  • 9.2.7 GOJO IndustriesInc
  • 9.2.8 MerativeInc
  • 9.2.9 VigiLanz Corporation
  • 9.2.10 RLDatix
  • 9.2.11 Ecolab Inc
  • 9.2.12 Harris Healthcare
  • 9.2.13 PeraHealthInc
  • 9.2.14 Medexter Healthcare GmbH
  • 9.2.15 CenTrakInc
  • 9.2.16 BioMerieux S.A
  • 9.2.17 PointClickCare Technologies Inc
  • 9.2.18 Vitalacy Inc
  • 9.2.19 BioVigil Healthcare Systems
  • 9.2.20 Vecna TechnologiesInc